| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
disease | 0.100 | None | 0.970 | 268 | 0 | 2002 | 2020 | |||||||||
|
interleukin 5 | 0.437 | 0.846 | 5.7E-03 |
|
disease | 0.700 | None | 0.973 | 175 | 0 | 1991 | 2020 | ||||||||
|
periostin | 0.428 | 0.885 | 1.1E-09 |
|
disease | 0.100 | None | 0.972 | 72 | 0 | 2006 | 2019 | ||||||||
|
FEV transcription factor, ETS family member | 0.593 | 0.692 | 8.1E-03 |
|
disease | 0.100 | None | 0.938 | 65 | 0 | 1999 | 2019 | ||||||||
|
hematopoietic prostaglandin D synthase | 0.388 | 0.923 | 1.8E-06 |
|
disease | 0.100 | None | 0.980 | 50 | 0 | 1997 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.400 | None | 0.896 | 45 | 0 | 2000 | 2019 | ||||||||
|
myeloid derived growth factor | 0.451 | 0.846 | 3.5E-06 |
|
disease | 0.100 | None | 1.000 | 39 | 0 | 2002 | 2020 | ||||||||
|
interleukin 25 | 0.529 | 0.846 | 9.2E-04 |
|
disease | 0.100 | None | 1.000 | 36 | 0 | 2002 | 2020 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
disease | 0.100 | None | 0.969 | 32 | 0 | 1996 | 2020 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.600 | None | 0.886 | 32 | 0 | 1996 | 2019 | ||||||||
|
immunoglobulin heavy constant epsilon | 0.626 | 0.538 |
|
disease | 0.100 | None | 0.966 | 28 | 0 | 1996 | 2018 | |||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
disease | 0.400 | None | 0.900 | 26 | 0 | 1999 | 2019 | ||||||||
|
glutathione S-transferase theta 1 | 0.393 | 0.923 | 1.5E-04 |
|
disease | 0.100 | None | 0.852 | 26 | 0 | 2000 | 2018 | ||||||||
|
leukotriene C4 synthase | 0.647 | 0.731 | 8.5E-04 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 2000 | 2019 | ||||||||
|
forkhead box P3 | 0.368 | 0.846 | 0.99 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 2004 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.300 | None | 0.963 | 26 | 0 | 1999 | 2019 | ||||||||
|
interleukin 22 | 0.393 | 0.885 | 1.9E-04 |
|
disease | 0.300 | None | 0.960 | 24 | 0 | 2009 | 2019 | ||||||||
|
mucin 5AC, oligomeric mucus/gel-forming | 0.483 | 0.808 | 1.0E-08 |
|
disease | 0.300 | None | 1.000 | 23 | 0 | 2001 | 2020 | ||||||||
|
Rho guanine nucleotide exchange factor 5 | 0.526 | 0.808 | 7.6E-14 |
|
disease | 0.100 | None | 0.913 | 23 | 0 | 2001 | 2017 | ||||||||
|
timeless circadian regulator | 0.533 | 0.808 | 9.8E-35 |
|
disease | 0.100 | None | 0.913 | 23 | 0 | 2001 | 2017 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.875 | 22 | 0 | 1997 | 2019 | ||||||||
|
glutathione S-transferase kappa 1 | 0.412 | 0.885 | 1.9E-06 |
|
disease | 0.100 | None | 0.955 | 22 | 0 | 1997 | 2016 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.200 | None | 1.000 | 21 | 0 | 2012 | 2020 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.947 | 19 | 0 | 2002 | 2019 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.400 | None | 1.000 | 18 | 0 | 1991 | 2020 |